Stock Events

Stock Events

Biocryst Pharmaceuticals (BO1.F) Q3 2024 Earnings

5AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.29

-0.21

-0.13

-0.05

Details

Expected EPS

-0.15791439999999998

Actual EPS

-0.054768

Surprise EPS

0.1

Surprise Percent

+65.32%

Description

Biocryst Pharmaceuticals (BO1.F) has reported earnings of -0.054768 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.